2014 AHA/ACC guideline for the management of patients with valvular heart disease: Executive summary: A report of the American college of cardiology/American heart association task force on practice guidelines

Journal of the American College of Cardiology

Volumn 63, Issue 22, 2014, Pages 2438-2488

  Nishimura, Rick A ^a   Otto, Catherine M ^a   Bonow, Robert O ^a   Carabello, Blase A ^a   Erwin III, John P ^a   Guyton, Robert A ^a   O'Gara, Patrick T ^a   Ruiz, Carlos E ^a   Skubas, Nikolaos J ^a   Sorajja, Paul ^a   Sundt III, Thoralf M ^a   Thomas, James D ^a  

^a NONE

Author keywords

ACC AHA Practice Guidelines; anticoagulation therapy; aortic regurgitation; aortic stenosis; bicuspid aortic valve; cardiac surgery; heart valves; infective endocarditis; mitral regurgitation; mitral stenosis; prosthetic valves; pulmonic regurgitation; pulmonic stenosis; transcatheter aortic valve replacement; tricuspid regurgitation; tricuspid stenosis; valvular heart disease

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ANTIVITAMIN K; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; VASODILATOR AGENT; WARFARIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL;

AMERICAN COLLEGE OF CARDIOLOGY; ANGIOCARDIOGRAPHY; AORTA DISEASE; AORTA STENOSIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AORTOPATHY; BACTERIAL ENDOCARDITIS; BICUSPID AORTIC VALVE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MAGNETIC RESONANCE; COMORBIDITY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HEART DISEASE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG WITHDRAWAL; EXERCISE TEST; GUIDELINE DIRECTED MEDICAL THERAPY; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HEART ATRIUM FIBRILLATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART VALVE COMMISSUROTOMY; HEART VALVE PROSTHESIS; HEART VALVE REGURGITATION; HEART VALVE STENOSIS; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; MEDICAL SOCIETY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE STENOSIS; PERCUTANEOUS BALLOON TRICUSPID COMMISSUROTOMY; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PROSTHETIC VALVE DYSFUNCTION; PROSTHETIC VALVE REGURGITATION; PROSTHETIC VALVE STENOSIS; PROSTHETIC VALVE THROMBOSIS; REVIEW; STRESS ECHOCARDIOGRAPHY; SYSTEMATIC REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; TRICUSPID VALVE STENOSIS; VALVULAR HEART DISEASE; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; BALLOON DILATATION; CHRONIC AORTIC REGURGITATION; CHRONIC PRIMARY MITRAL REGURGITATION; CHRONIC SECONDARY MITRAL REGURGITATION; CLINICAL EVALUATION; DISEASE CLASSIFICATION; DOCUMENT EXAMINATION; DRUG CONTRAINDICATION; EMERGENCY SURGERY; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART CATHETERIZATION; INTERVENTIONAL RISK; MEDICAL DECISION MAKING; MEDICAL DEVICE COMPLICATION; MEDICAL DOCUMENTATION; MITRAL VALVE COMMISSUROTOMY; NATIVE VALVE REGURGITATION; NATIVE VALVE STENOSIS; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS MITRAL BALLOON COMMISSUROTOMY; PULMONARY VALVE DISEASE; RISK; RISK ASSESSMENT; SURGICAL RISK; TIME TO TREATMENT; TREATMENT INDICATION; TRICUSPID VALVE REPAIR;

ACC/AHA PRACTICE GUIDELINES; ANTICOAGULATION THERAPY; AORTIC REGURGITATION; AORTIC STENOSIS; BICUSPID AORTIC VALVE; CARDIAC SURGERY; HEART VALVES; INFECTIVE ENDOCARDITIS; MITRAL REGURGITATION; MITRAL STENOSIS; PROSTHETIC VALVES; PULMONIC REGURGITATION; PULMONIC STENOSIS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TRICUSPID REGURGITATION; TRICUSPID STENOSIS; VALVULAR HEART DISEASE;

DECISION TREES; HEART VALVE DISEASES; HUMANS; UNITED STATES;

EID: 84902074215     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.02.537     Document Type: Article

References (411)

1. ACCF/AHA Task Force on Practice Guidelines. Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines. American College of Cardiology Foundation and American Heart Association, Inc. cardiosource.org. 2010. Available at: http://assets.cardiosource.com/Methodology-Manual-for-ACC- AHA-Writing-Committees.pdf and http://my.americanheart.org/idc/groups/ahamah- public/@wcm/@sop/documents/downloadable/ucm-319826.pdf. Accessed February 24, 2014.
2. Committee on Standards for Developing Trustworthy Clinical Practice Guidelines; Institute of Medicine Clinical Practice Guidelines We Can Trust 2013 The National Academies Press Washington, D.C.
3. Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, Institute of Medicine Finding What Works in Health Care: Standards for Systematic Reviews 2011 The National Academies Press Washington, DC
4. Nishimura R, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol In press.
5. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease).
6. W.A. Zoghbi, M. Enriquez-Sarano, and E. Foster et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography J Am Soc Echocardiogr 16 2003 777 802
7. Deleted in press.
8. C.A. Warnes, R.G. Williams, and T.M. Bashore et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 52 2008 e143 e263
9. H. Baumgartner, J. Hung, and J. Bermejo et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice Eur J Echocardiogr 10 2009 1 25
10. W.A. Zoghbi, J.B. Chambers, and J.G. Dumesnil et al. Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography J Am Soc Echocardiogr 22 2009 975 1014
11. B.J. Gersh, B.J. Maron, and R.O. Bonow et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 58 2011 e212 e260
12. V. Regitz-Zagrosek, L.C. Blomstrom, and C. Borghi et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) Eur Heart J 32 2011 3147 3197
13. R.P. Whitlock, J.C. Sun, and S.E. Fremes et al. Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e576S e600S
14. A. Vahanian, O. Alfieri, and F. Andreotti et al. Guidelines on the management of valvular heart disease (version 2012) Eur Heart J 33 2012 2451 2496
15. C.W. Yancy, M. Jessup, and B. Bozkurt et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
16. C.T. January, L.S. Wann, and J.S. Alpert et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Developed in Collaboration With the Society of Thoracic Surgeons J Am Coll Cardiol 2014 Mar 28 [E-pub ahead of print]; http://dx.doi.org/10.1016/j.jacc.2014.03.022
17. Deleted in press.
18. Deleted in press.
19. B.A. Carabello, H. Williams, and A.K. Gash et al. Hemodynamic predictors of outcome in patients undergoing valve replacement Circulation 74 1986 1309 1316
20. P.J. Currie, J.B. Seward, and K.L. Chan et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler- catheterization study in 127 patients J Am Coll Cardiol 6 1985 750 756
21. P.J. Currie, J.B. Seward, and G.S. Reeder et al. Continuous-wave Doppler echocardiographic assessment of severity of calcific aortic stenosis: a simultaneous Doppler-catheter correlative study in 100 adult patients Circulation 71 1985 1162 1169
22. K.S. Dujardin, J.B. Seward, and T.A. Orszulak et al. Outcome after surgery for mitral regurgitation. Determinants of postoperative morbidity and mortality J Heart Valve Dis 6 1997 17 21
23. M. Enriquez-Sarano, J.F. Avierinos, and D. Messika-Zeitoun et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation N Engl J Med 352 2005 875 883
24. M. Enriquez-Sarano, A.J. Tajik, and H.V. Schaff et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications J Am Coll Cardiol 24 1994 1536 1543
25. R.A. Nishimura, C.S. Rihal, and A.J. Tajik et al. Accurate measurement of the transmitral gradient in patients with mitral stenosis: a simultaneous catheterization and Doppler echocardiographic study J Am Coll Cardiol 24 1994 152 158
26. J.K. Oh, C.P. Taliercio, and D.R.J. Holmes et al. Prediction of the severity of aortic stenosis by Doppler aortic valve area determination: prospective Doppler-catheterization correlation in 100 patients J Am Coll Cardiol 11 1988 1227 1234
27. C.M. Otto, I.G. Burwash, and M.E. Legget et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome Circulation 95 1997 2262 2270
28. C.M. Otto, R.A. Nishimura, and K.B. Davis et al. Doppler echocardiographic findings in adults with severe symptomatic valvular aortic stenosis. Balloon Valvuloplasty Registry Echocardiographers Am J Cardiol 68 1991 1477 1484
29. C.M. Otto, A.S. Pearlman, and K.A. Comess et al. Determination of the stenotic aortic valve area in adults using Doppler echocardiography J Am Coll Cardiol 7 1986 509 517
30. C.M. Otto, A.S. Pearlman, and C.L. Gardner Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography J Am Coll Cardiol 13 1989 545 550
31. P.A. Pellikka, M.E. Sarano, and R.A. Nishimura et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up Circulation 111 2005 3290 3295
32. M.R. Zile, W.H. Gaasch, and J.D. Carroll et al. Chronic mitral regurgitation: predictive value of preoperative echocardiographic indexes of left ventricular function and wall stress J Am Coll Cardiol 3 1984 235 242
33. K.S. Dujardin, M. Enriquez-Sarano, and H.V. Schaff et al. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study Circulation 99 1999 1851 1857
34. R.O. Bonow, E. Lakatos, and B.J. Maron et al. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function Circulation 84 1991 1625 1635
35. R.J. Aviles, R.A. Nishimura, and P.A. Pellikka et al. Utility of stress Doppler echocardiography in patients undergoing percutaneous mitral balloon valvotomy J Am Soc Echocardiogr 14 2001 676 681
36. C.M. Otto, A.S. Pearlman, and C.D. Kraft et al. Physiologic changes with maximal exercise in asymptomatic valvular aortic stenosis assessed by Doppler echocardiography J Am Coll Cardiol 20 1992 1160 1167
37. P. Lancellotti, F. Lebois, and M. Simon et al. Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis Circulation 112 2005 I377 I382
38. S. Marechaux, Z. Hachicha, and A. Bellouin et al. Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis Eur Heart J 31 2010 1390 1397
39. D. Messika-Zeitoun, B.D. Johnson, and V. Nkomo et al. Cardiopulmonary exercise testing determination of functional capacity in mitral regurgitation: physiologic and outcome implications J Am Coll Cardiol 47 2006 2521 2527
40. M.A. Gerber, R.S. Baltimore, and C.B. Eaton et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research Circulation 119 2009 1541 1551
41. D. Horstkotte Contribution for choosing the optimal prophylaxis of bacterial endocarditis Eur Heart J 1987 379 381
42. B.L. Strom, E. Abrutyn, and J.A. Berlin et al. Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study Ann Intern Med 129 1998 761 769
43. X. Duval, F. Alla, and B. Hoen et al. Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic prophylaxis Clin Infect Dis 42 2006 e102 e107
44. C. Guarner-Argente, P. Shah, and A. Buchner et al. Use of antimicrobials for EUS-guided FNA of pancreatic cysts: a retrospective, comparative analysis Gastrointest Endosc 74 2011 81 86
45. A. Galan, W.A. Zoghbi, and M.A. Quinones Determination of severity of valvular aortic stenosis by Doppler echocardiography and relation of findings to clinical outcome and agreement with hemodynamic measurements determined at cardiac catheterization Am J Cardiol 67 1991 1007 1012
46. S.S. Lin, V.L. Roger, and R. Pascoe et al. Dobutamine stress Doppler hemodynamics in patients with aortic stenosis: feasibility, safety, and surgical correlations Am Heart J 136 1998 1010 1016
47. J.L. Monin, M. Monchi, and V. Gest et al. Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardiography J Am Coll Cardiol 37 2001 2101 2107
48. M.A. Clavel, C. Fuchs, and I.G. Burwash et al. Predictors of outcomes in low-flow, low-gradient aortic stenosis: results of the multicenter TOPAS Study Circulation 118 2008 S234 S242
49. P. Das, H. Rimington, and J. Chambers Exercise testing to stratify risk in aortic stenosis Eur Heart J 26 2005 1309 1313
50. J.H. Atterhog, B. Jonsson, and R. Samuelsson Exercise testing: a prospective study of complication rates Am Heart J 98 1979 572 579
51. K.D. O'Brien, X.Q. Zhao, and D.M. Shavelle et al. Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function J Investig Med 52 2004 185 191
52. A. Chockalingam, S. Venkatesan, and T. Subramaniam et al. Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS) Am Heart J 147 2004 E19
53. M.A. Nadir, L. Wei, and D.H. Elder et al. Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis J Am Coll Cardiol 58 2011 570 576
54. A.B. Rossebo, T.R. Pedersen, and K. Boman et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis N Engl J Med 359 2008 1343 1356
55. S.J. Cowell, D.E. Newby, and R.J. Prescott et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis N Engl J Med 352 2005 2389 2397
56. K.L. Chan, K. Teo, and J.G. Dumesnil et al. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial Circulation 121 2010 306 314
57. C.M. Otto, and A.S. Pearlman Doppler echocardiography in adults with symptomatic aortic stenosis. Diagnostic utility and cost-effectiveness Arch Intern Med 148 1988 2553 2560
58. J. Turina, O. Hess, and F. Sepulcri et al. Spontaneous course of aortic valve disease Eur Heart J 8 1987 471 483
59. T.A. Kelly, R.M. Rothbart, and C.M. Cooper et al. Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis Am J Cardiol 61 1988 123 130
60. H.M. Connolly, J.K. Oh, and T.A. Orszulak et al. Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction. Prognostic indicators Circulation 95 1997 2395 2400
61. C. Tribouilloy, F. Levy, and D. Rusinaru et al. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography J Am Coll Cardiol 53 2009 1865 1873
62. R. Rosenhek, T. Binder, and G. Porenta et al. Predictors of outcome in severe, asymptomatic aortic stenosis N Engl J Med 343 2000 611 617
63. W.T. Smith, T.B. Ferguson Jr., and T. Ryan et al. Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement? A decision analysis approach to the surgical dilemma J Am Coll Cardiol 44 2004 1241 1247
64. P. Lancellotti, E. Donal, and J. Magne et al. Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay Heart 96 2010 1364 1371
65. R. Rosenhek, R. Zilberszac, and M. Schemper et al. Natural history of very severe aortic stenosis Circulation 121 2010 151 156
66. R.A. Nishimura, J.A. Grantham, and H.M. Connolly et al. Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory Circulation 106 2002 809 813
67. J.L. Monin, J.P. Quere, and M. Monchi et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics Circulation 108 2003 319 324
68. E. Fougeres, C. Tribouilloy, and M. Monchi et al. Outcomes of pseudo-severe aortic stenosis under conservative treatment Eur Heart J 33 2012 2426 2433
69. D. Horstkotte, and F. Loogen The natural history of aortic valve stenosis Eur Heart J 9 Suppl E 1988 57 64
70. S.M. O'Brien, D.M. Shahian, and G. Filardo et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2 - isolated valve surgery Ann Thorac Surg 88 2009 S23 S42
71. S.K. Kodali, M.R. Williams, and C.R. Smith et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement N Engl J Med 366 2012 1686 1695
72. M.B. Leon, C.R. Smith, and M. Mack et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
73. R.R. Makkar, G.P. Fontana, and H. Jilaihawi et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis N Engl J Med 366 2012 1696 1704
74. C.R. Smith, M.B. Leon, and M.J. Mack et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
75. D. Detaint, D. Messika-Zeitoun, and J. Maalouf et al. Quantitative echocardiographic determinants of clinical outcome in asymptomatic patients with aortic regurgitation: a prospective study J Am Coll Cardiol Img 1 2008 1 11
76. R. Pizarro, O.O. Bazzino, and P.F. Oberti et al. Prospective validation of the prognostic usefulness of B-type natriuretic peptide in asymptomatic patients with chronic severe aortic regurgitation J Am Coll Cardiol 58 2011 1705 1714
77. S.M. Teague, J.A. Heinsimer, and J.L. Anderson et al. Quantification of aortic regurgitation utilizing continuous wave Doppler ultrasound J Am Coll Cardiol 8 1986 592 599
78. R.O. Bonow, D.R. Rosing, and C.L. McIntosh et al. The natural history of asymptomatic patients with aortic regurgitation and normal left ventricular function Circulation 68 1983 509 517
79. R. Scognamiglio, G. Fasoli, and V.S. Dalla Progression of myocardial dysfunction in asymptomatic patients with severe aortic insufficiency Clin Cardiol 9 1986 151 156
80. D. Siemienczuk, B. Greenberg, and C. Morris et al. Chronic aortic insufficiency: factors associated with progression to aortic valve replacement Ann Intern Med 110 1989 587 592
81. M.P. Tornos, M. Olona, and G. Permanyer-Miralda et al. Clinical outcome of severe asymptomatic chronic aortic regurgitation: a long-term prospective follow-up study Am Heart J 130 1995 333 339
82. K. Ishii, Y. Hirota, and M. Suwa et al. Natural history and left ventricular response in chronic aortic regurgitation Am J Cardiol 78 1996 357 361
83. R. Scognamiglio, S.H. Rahimtoola, and G. Fasoli et al. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function N Engl J Med 331 1994 689 694
84. J.S. Borer, C. Hochreiter, and E.M. Herrold et al. Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance Circulation 97 1998 525 534
85. J.C.H. Attenhofer, J. Turina, and K. Mayer et al. Echocardiography in the evaluation of systolic murmurs of unknown cause Am J Med 2000 614 620
86. E.V. Gelfand, S. Hughes, and T.H. Hauser et al. Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography J Cardiovasc Magn Reson 8 2006 503 507
87. P.J. Cawley, C. Hamilton-Craig, and D.S. Owens et al. Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography Circ Cardiovasc Imaging 6 2013 48 57
88. A. Evangelista, P. Tornos, and A. Sambola et al. Long-term vasodilator therapy in patients with severe aortic regurgitation N Engl J Med 353 2005 1342 1349
89. L. Sondergaard, J. Aldershvile, and P. Hildebrandt et al. Vasodilatation with felodipine in chronic asymptomatic aortic regurgitation Am Heart J 139 2000 667 674
90. D.H. Elder, L. Wei, and B.R. Szwejkowski et al. The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study J Am Coll Cardiol 58 2011 2084 2091
91. J. Greves, S.H. Rahimtoola, and J.H. McAnulty et al. Preoperative criteria predictive of late survival following valve replacement for severe aortic regurgitation Am Heart J 101 1981 300 308
92. E. Klodas, M. Enriquez-Sarano, and A.J. Tajik et al. Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms J Am Coll Cardiol 30 1997 746 752
93. R. Forman, B.G. Firth, and M.S. Barnard Prognostic significance of preoperative left ventricular ejection fraction and valve lesion in patients with aortic valve replacement Am J Cardiol 45 1980 1120 1125
94. H.P. Chaliki, D. Mohty, and J.F. Avierinos et al. Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function Circulation 106 2002 2687 2693
95. S.K. Bhudia, P.M. McCarthy, and G.S. Kumpati et al. Improved outcomes after aortic valve surgery for chronic aortic regurgitation with severe left ventricular dysfunction J Am Coll Cardiol 49 2007 1465 1471
96. R.O. Bonow, J.T. Dodd, and B.J. Maron et al. Long-term serial changes in left ventricular function and reversal of ventricular dilatation after valve replacement for chronic aortic regurgitation Circulation 78 1988 1108 1120
97. A.C. Van Rossum, F.C. Visser, and M. Sprenger et al. Evaluation of magnetic resonance imaging for determination of left ventricular ejection fraction and comparison with angiography Am J Cardiol 62 1988 628 633
98. W.H. Gaasch, J.D. Carroll, and H.J. Levine et al. Chronic aortic regurgitation: prognostic value of left ventricular end-systolic dimension and end-diastolic radius/thickness ratio J Am Coll Cardiol 1 1983 775 782
99. R.T. Pachulski, A.L. Weinberg, and K.L. Chan Aortic aneurysm in patients with functionally normal or minimally stenotic bicuspid aortic valve Am J Cardiol 67 1991 781 782
100. R.T. Hahn, M.J. Roman, and A.H. Mogtader et al. Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves J Am Coll Cardiol 19 1992 283 288
101. S. Nistri, M.D. Sorbo, and M. Marin et al. Aortic root dilatation in young men with normally functioning bicuspid aortic valves Heart 82 1999 19 22
102. M.G. Keane, S.E. Wiegers, and T. Plappert et al. Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions Circulation 102 2000 III35 III39
103. G.M. Novaro, I.Y. Tiong, and G.L. Pearce et al. Features and predictors of ascending aortic dilatation in association with a congenital bicuspid aortic valve Am J Cardiol 92 2003 99 101
104. B.M. Schaefer, M.B. Lewin, and K.K. Stout et al. The bicuspid aortic valve: an integrated phenotypic classification of leaflet morphology and aortic root shape Heart 94 2008 1634 1638
105. N. Tzemos, J. Therrien, and J. Yip et al. Outcomes in adults with bicuspid aortic valves JAMA 300 2008 1317 1325
106. H.I. Michelena, A.D. Khanna, and D. Mahoney et al. Incidence of aortic complications in patients with bicuspid aortic valves JAMA 306 2011 1104 1112
107. R.R. Davies, L.J. Goldstein, and M.A. Coady et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size Ann Thorac Surg 73 2002 17 27
108. R. Arora, M. Nair, and G.S. Kalra et al. Immediate and long-term results of balloon and surgical closed mitral valvotomy: a randomized comparative study Am Heart J 125 1993 1091 1094
109. Z.G. Turi, V.P. Reyes, and B.S. Raju et al. Percutaneous balloon versus surgical closed commissurotomy for mitral stenosis. A prospective, randomized trial Circulation 83 1991 1179 1185
110. J.J. Patel, D. Shama, and A.S. Mitha et al. Balloon valvuloplasty versus closed commissurotomy for pliable mitral stenosis: a prospective hemodynamic study J Am Coll Cardiol 18 1991 1318 1322
111. F.M. Ben, M. Ayari, and F. Maatouk et al. Percutaneous balloon versus surgical closed and open mitral commissurotomy: seven-year follow-up results of a randomized trial Circulation 97 1998 245 250
112. M. Cotrufo, A. Renzulli, and G. Ismeno et al. Percutaneous mitral commissurotomy versus open mitral commissurotomy: a comparative study Eur J Cardiothorac Surg 15 1999 646 651
113. P.G. Hugenholtz, T.J. Ryan, and S.W. Stein et al. The spectrum of pure mitral stenosis. Hemodynamic studies in relation to clinical disability Am J Cardiol 10 1962 773 784
114. V.P. Reyes, B.S. Raju, and J. Wynne et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis N Engl J Med 331 1994 961 967
115. L. Sugeng, L. Weinert, and G. Lammertin et al. Accuracy of mitral valve area measurements using transthoracic rapid freehand 3-dimensional scanning: comparison with noninvasive and invasive methods J Am Soc Echocardiogr 16 2003 1292 1300
116. D. Schlosshan, G. Aggarwal, and G. Mathur et al. Real-time 3D transesophageal echocardiography for the evaluation of rheumatic mitral stenosis J Am Coll Cardiol Img 4 2011 580 588
117. J.I. Leavitt, M.H. Coats, and R.H. Falk Effects of exercise on transmitral gradient and pulmonary artery pressure in patients with mitral stenosis or a prosthetic mitral valve: a Doppler echocardiographic study J Am Coll Cardiol 17 1991 1520 1526
118. C.S. Chung, M. Karamanoglu, and S.J. Kovacs Duration of diastole and its phases as a function of heart rate during supine bicycle exercise Am J Physiol Heart Circ Physiol 287 2004 H2003 H2008
119. W.A. Zoghbi, J.B. Chambers, and J.G. Dumesnil et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography J Am Soc Echocardiogr 22 2009 975 1014
120. G.T. Wilkins, A.E. Weyman, and V.M. Abascal et al. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation Br Heart J 60 1988 299 308
121. V.M. Abascal, G.T. Wilkins, and J.P. O'Shea et al. Prediction of successful outcome in 130 patients undergoing percutaneous balloon mitral valvotomy Circulation 82 1990 448 456
122. C.R. Cannan, R.A. Nishimura, and G.S. Reeder et al. Echocardiographic assessment of commissural calcium: a simple predictor of outcome after percutaneous mitral balloon valvotomy J Am Coll Cardiol 29 1997 175 180
123. J.D. Thomas, G.T. Wilkins, and C.Y. Choong et al. Inaccuracy of mitral pressure half-time immediately after percutaneous mitral valvotomy. Dependence on transmitral gradient and left atrial and ventricular compliance Circulation 78 1988 980 993
124. K. Ellis, K.M. Ziada, and D. Vivekananthan et al. Transthoracic echocardiographic predictors of left atrial appendage thrombus Am J Cardiol 97 2006 421 425
125. I. Kronzon, P.A. Tunick, and E. Glassman et al. Transesophageal echocardiography to detect atrial clots in candidates for percutaneous transseptal mitral balloon valvuloplasty J Am Coll Cardiol 16 1990 1320 1322
126. P. Tessier, L.A. Mercier, and D. Burelle et al. Results of percutaneous mitral commissurotomy in patients with a left atrial appendage thrombus detected by transesophageal echocardiography J Am Soc Echocardiogr 7 1994 394 399
127. J.K. Wilson, and W.F. Greenwood The natural history of mitral stenosis Can Med Assoc J 71 1954 323 331
128. J.C. Rowe, E.F. Bland, and H.B. Sprague et al. The course of mitral stenosis without surgery: ten- and twenty-year perspectives Ann Intern Med 52 1960 741 749
129. K.H. Olesen The natural history of 271 patients with mitral stenosis under medical treatment Br Heart J 24 1962 349 357
130. P. Szekely Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease Br Med J 1 1964 1209 1212
131. F. Perez-Gomez, E. Alegria, and J. Berjon et al. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study J Am Coll Cardiol 44 2004 1557 1566
132. H. Omran, B. Rang, and H. Schmidt et al. Incidence of left atrial thrombi in patients in sinus rhythm and with a recent neurologic deficit Am Heart J 140 2000 658 662
133. D.E. Singer, G.W. Albers, and J.E. Dalen et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 546S 592S
134. B.C. Stoll, T.L. Ashcom, and J.P. Johns et al. Effects of atenolol on rest and exercise hemodynamics in patients with mitral stenosis Am J Cardiol 75 1995 482 484
135. J.V. Monmeneu Menadas, O.F. Marin, and G.F. Reyes et al. Beta-blockade and exercise capacity in patients with mitral stenosis in sinus rhythm J Heart Valve Dis 11 2002 199 203
136. C. Bouleti, B. Iung, and C. Laouenan et al. Late results of percutaneous mitral commissurotomy up to 20 years: development and validation of a risk score predicting late functional results from a series of 912 patients Circulation 125 2012 2119 2127
137. L.B. Ellis, J.B. Singh, and D.D. Morales et al. Fifteen-to twenty-year study of one thousand patients undergoing closed mitral valvuloplasty Circulation 48 1973 357 364
138. S. John, V.V. Bashi, and P.S. Jairaj et al. Closed mitral valvotomy: early results and long-term follow-up of 3724 consecutive patients Circulation 68 1983 891 896
139. J.O. Finnegan, D.C. Gray, and H. MacVaugh III et al. The open approach to mitral commissurotomy J Thorac Cardiovasc Surg 67 1974 75 82
140. M.J. Mullin, R.M. Engelman, and O.W. Isom et al. Experience with open mitral commissurotomy in 100 consecutive patients Surgery 76 1974 974 982
141. W.L. Halseth, D.P. Elliott, and E.L. Walker et al. Open mitral commissurotomy. A modern re-evaluation J Thorac Cardiovasc Surg 80 1980 842 848
142. R.I. Gross, J.N. Cunningham Jr., and S.L. Snively et al. Long-term results of open radical mitral commissurotomy: ten year follow-up study of 202 patients Am J Cardiol 47 1981 821 825
143. B. Iung, B. Cormier, and P. Ducimetiere et al. Functional results 5 years after successful percutaneous mitral commissurotomy in a series of 528 patients and analysis of predictive factors J Am Coll Cardiol 27 1996 407 414
144. N. Arat, H. Altay, and S. Korkmaz et al. The effect of baseline pulmonary artery pressure on right ventricular functions after mitral balloon valvuloplasty for rheumatic mitral stenosis: a tissue Doppler imaging study Turk Kardiyol Dern Ars 36 2008 223 230
145. J.J. Vincens, D. Temizer, and J.R. Post et al. Long-term outcome of cardiac surgery in patients with mitral stenosis and severe pulmonary hypertension Circulation 92 1995 II137 II142
146. F. Recusani, G.S. Bargiggia, and A.P. Yoganathan et al. A new method for quantification of regurgitant flow rate using color Doppler flow imaging of the flow convergence region proximal to a discrete orifice. An in vitro study Circulation 83 1991 594 604
147. G.S. Bargiggia, L. Tronconi, and D.J. Sahn et al. A new method for quantitation of mitral regurgitation based on color flow Doppler imaging of flow convergence proximal to regurgitant orifice Circulation 84 1991 1481 1489
148. J.M. Rivera, P.M. Vandervoort, and D.H. Thoreau et al. Quantification of mitral regurgitation with the proximal flow convergence method: a clinical study Am Heart J 124 1992 1289 1296
149. R. Rosenhek, F. Rader, and U. Klaar et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation Circulation 113 2006 2238 2244
150. M.H. Crawford, J. Souchek, and C.A. Oprian et al. Determinants of survival and left ventricular performance after mitral valve replacement. Department of Veterans Affairs Cooperative Study on Valvular Heart Disease Circulation 81 1990 1173 1181
151. M. Enriquez-Sarano, A.J. Tajik, and H.V. Schaff et al. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation Circulation 90 1994 830 837
152. C. Tribouilloy, F. Grigioni, and J.F. Avierinos et al. Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study J Am Coll Cardiol 54 2009 1961 1968
153. F. Grigioni, C. Tribouilloy, and J.F. Avierinos et al. Outcomes in mitral regurgitation due to flail leaflets a multicenter European study J Am Coll Cardiol Img 1 2008 133 141
154. M. Ghoreishi, C.F. Evans, and C.R. deFilippi et al. Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery J Thorac Cardiovasc Surg 142 2011 1439 1452
155. J.D. Rozich, B.A. Carabello, and B.W. Usher et al. Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation. Mechanisms for differences in postoperative ejection performance Circulation 86 1992 1718 1726
156. C.M. Tribouilloy, M. Enriquez-Sarano, and H.V. Schaff et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications Circulation 99 1999 400 405
157. P.W. Pflugfelder, U.P. Sechtem, and R.D. White et al. Noninvasive evaluation of mitral regurgitation by analysis of left atrial signal loss in cine magnetic resonance Am Heart J 117 1989 1113 1119
158. M. Pu, D.L. Prior, and X. Fan et al. Calculation of mitral regurgitant orifice area with use of a simplified proximal convergence method: initial clinical application J Am Soc Echocardiogr 14 2001 180 185
159. M. Pu, P.M. Vandervoort, and N.L. Greenberg et al. Impact of wall constraint on velocity distribution in proximal flow convergence zone. Implications for color Doppler quantification of mitral regurgitation J Am Coll Cardiol 27 1996 706 713
160. R.M. Lang, L.P. Badano, and W. Tsang et al. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography J Am Soc Echocardiogr 25 2012 3 46
161. T.G. Witkowski, J.D. Thomas, and P.J. Debonnaire et al. Global longitudinal strain predicts left ventricular dysfunction after mitral valve repair Eur Heart J Cardiovasc Imaging 14 2013 69 76
162. J. Magne, H. Mahjoub, and L.A. Pierard et al. Prognostic importance of brain natriuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation Heart 98 2012 584 591
163. O. Ozdogan, A. Yuksel, and C. Gurgun et al. Evaluation of the severity of mitral regurgitation by the use of signal void in magnetic resonance imaging Echocardiography 26 2009 1127 1135
164. S.G. Myerson, J.M. Francis, and S. Neubauer Direct and indirect quantification of mitral regurgitation with cardiovascular magnetic resonance, and the effect of heart rate variability MAGMA 23 2010 243 249
165. M. Dahm, S. Iversen, and F.X. Schmid et al. Intraoperative evaluation of reconstruction of the atrioventricular valves by transesophageal echocardiography Thorac Cardiovasc Surg 35 Spec No 2 1987 140 142
166. Y. Saiki, H. Kasegawa, and M. Kawase et al. Intraoperative TEE during mitral valve repair: does it predict early and late postoperative mitral valve dysfunction? Ann Thorac Surg 66 1998 1277 1281
167. M.D. Tischler, K.A. Cooper, and M. Rowen et al. Mitral valve replacement versus mitral valve repair. A Doppler and quantitative stress echocardiographic study Circulation 89 1994 132 137
168. J. Magne, P. Lancellotti, and L.A. Pierard Exercise-induced changes in degenerative mitral regurgitation J Am Coll Cardiol 56 2010 300 309
169. H. Tsutsui, F.G. Spinale, and M. Nagatsu et al. Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation J Clin Invest 93 1994 2639 2648
170. P. Varadarajan, N. Joshi, and D. Appel et al. Effect of Beta-blocker therapy on survival in patients with severe mitral regurgitation and normal left ventricular ejection fraction Am J Cardiol 102 2008 611 615
171. M.I. Ahmed, I. Aban, and S.G. Lloyd et al. A randomized controlled phase IIb trial of beta(1)-receptor blockade for chronic degenerative mitral regurgitation J Am Coll Cardiol 60 2012 833 838
172. S. Nemoto, M. Hamawaki, and G. De Freitas et al. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation J Am Coll Cardiol 40 2002 149 154
173. H.R. Schon Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation J Hypertens Suppl 12 1994 S95 S104
174. M.D. Tischler, M. Rowan, and M.M. LeWinter Effect of enalapril therapy on left ventricular mass and volumes in asymptomatic chronic, severe mitral regurgitation secondary to mitral valve prolapse Am J Cardiol 82 1998 242 245
175. T. Wisenbaugh, V. Sinovich, and A. Dullabh et al. Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation J Heart Valve Dis 3 1994 197 204
176. K.S. Dujardin, M. Enriquez-Sarano, and K.R. Bailey et al. Effect of losartan on degree of mitral regurgitation quantified by echocardiography Am J Cardiol 87 2001 570 576
177. K.M. Harris, D.M. Aeppli, and C.F. Carey Effects of angiotensin- converting enzyme inhibition on mitral regurgitation severity, left ventricular size, and functional capacity Am Heart J 150 2005 1106
178. A.M. Kizilbash, D.L. Willett, and M.E. Brickner et al. Effects of afterload reduction on vena contracta width in mitral regurgitation J Am Coll Cardiol 32 1998 427 431
179. A.M. Gillinov, T. Mihaljevic, and E.H. Blackstone et al. Should patients with severe degenerative mitral regurgitation delay surgery until symptoms develop? Ann Thorac Surg 90 2010 481 488
180. F. Grigioni, M. Enriquez-Sarano, and L.H. Ling et al. Sudden death in mitral regurgitation due to flail leaflet J Am Coll Cardiol 34 1999 2078 2085
181. G. Schuler, K.L. Peterson, and A. Johnson et al. Temporal response of left ventricular performance to mitral valve surgery Circulation 59 1979 1218 1231
182. M.R. Starling Effects of valve surgery on left ventricular contractile function in patients with long-term mitral regurgitation Circulation 92 1995 811 818
183. R.F. Rushmer Initial phase of ventricular systole: asynchronous contraction Am J Physiol 184 1956 188 194
184. D.E. Hansen, G.E. Sarris, and M.A. Niczyporuk et al. Physiologic role of the mitral apparatus in left ventricular regional mechanics, contraction synergy, and global systolic performance J Thorac Cardiovasc Surg 97 1989 521 533
185. G.E. Sarris, P.D. Cahill, and D.E. Hansen et al. Restoration of left ventricular systolic performance after reattachment of the mitral chordae tendineae. The importance of valvular-ventricular interaction J Thorac Cardiovasc Surg 95 1988 969 979
186. M.E. Goldman, F. Mora, and T. Guarino et al. Mitral valvuloplasty is superior to valve replacement for preservation of left ventricular function: an intraoperative two-dimensional echocardiographic study J Am Coll Cardiol 10 1987 568 575
187. T.E. David, R.J. Burns, and C.M. Bacchus et al. Mitral valve replacement for mitral regurgitation with and without preservation of chordae tendineae J Thorac Cardiovasc Surg 88 1984 718 725
188. H.A. Hennein, J.A. Swain, and C.L. McIntosh et al. Comparative assessment of chordal preservation versus chordal resection during mitral valve replacement J Thorac Cardiovasc Surg 99 1990 828 836
189. L.H. Cohn Surgery for mitral regurgitation JAMA 260 1988 2883 2887
190. D.M. Cosgrove, A.M. Chavez, and B.W. Lytle et al. Results of mitral valve reconstruction Circulation 74 1986 I82 I87
191. STS online risk calculator. Available at: http://riskcalc.sts.org/ STSWebRiskCalc273/de.aspx. 2013. Accessed February 24, 2014.
192. T.E. David, D.E. Uden, and H.D. Strauss The importance of the mitral apparatus in left ventricular function after correction of mitral regurgitation Circulation 68 1983 II76 II82
193. D. Horskotte, H.D. Schulte, and W. Bircks et al. The effect of chordal preservation on late outcome after mitral valve replacement: a randomized study J Heart Valve Dis 2 1993 150 158
194. C.M. Vassileva, G. Mishkel, and C. McNeely et al. Long-Term survival of patients undergoing mitral valve repair and replacement: a longitudinal analysis of Medicare fee-for-service beneficiaries Circulation 127 2013 1870 1876
195. E. Braunberger, A. Deloche, and A. Berrebi et al. Very long-term results (more than 20 years) of valve repair with carpentier's techniques in nonrheumatic mitral valve insufficiency Circulation 104 2001 I8 11
196. T.E. David, J. Ivanov, and S. Armstrong et al. A comparison of outcomes of mitral valve repair for degenerative disease with posterior, anterior, and bileaflet prolapse J Thorac Cardiovasc Surg 130 2005 1242 1249
197. R.S. McClure, L.V. Athanasopoulos, and S. McGurk et al. One thousand minimally invasive mitral valve operations: early outcomes, late outcomes, and echocardiographic follow-up J Thorac Cardiovasc Surg 145 2013 1199 1206
198. J.S. Gammie, S. Sheng, and B.P. Griffith et al. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database Ann Thorac Surg 87 2009 1431 1437
199. J. Chikwe, A.B. Goldstone, and J. Passage et al. A propensity score-adjusted retrospective comparison of early and mid-term results of mitral valve repair versus replacement in octogenarians Eur Heart J 32 2011 618 626
200. V. Badhwar, E.D. Peterson, and J.P. Jacobs et al. Longitudinal outcome of isolated mitral repair in older patients: results from 14,604 procedures performed from 1991 to 2007 Ann Thorac Surg 94 2012 1870 1877
201. E.A. Grossi, A.C. Galloway, and J.S. Miller et al. Valve repair versus replacement for mitral insufficiency: when is a mechanical valve still indicated? J Thorac Cardiovasc Surg 115 1998 389 394
202. S. Chauvaud, J.F. Fuzellier, and A. Berrebi et al. Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency Circulation 104 2001 I12 I15
203. S.F. Bolling, S. Li, and S.M. O'Brien et al. Predictors of mitral valve repair: clinical and surgeon factors Ann Thorac Surg 90 2010 1904 1911
204. A.M. Gillinov, E.H. Blackstone, and D.M. Cosgrove III et al. Mitral valve repair with aortic valve replacement is superior to double valve replacement J Thorac Cardiovasc Surg 125 2003 1372 1387
205. D.H. Kang, J.H. Kim, and J.H. Rim et al. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation Circulation 119 2009 797 804
206. A.M. Gillinov, E.H. Blackstone, and E.R. Nowicki et al. Valve repair versus valve replacement for degenerative mitral valve disease J Thorac Cardiovasc Surg 135 2008 885 893 893
207. C.M. Duran, B. Gometza, and E. Saad Valve repair in rheumatic mitral disease: an unsolved problem J Card Surg 9 1994 282 285
208. R.M. Suri, J.L. Vanoverschelde, and F. Grigioni et al. Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets JAMA 310 2013 609 616
209. R.M. Suri, H.V. Schaff, and J.A. Dearani et al. Recovery of left ventricular function after surgical correction of mitral regurgitation caused by leaflet prolapse J Thorac Cardiovasc Surg 137 2009 1071 1076
210. D.L. Ngaage, H.V. Schaff, and C.J. Mullany et al. Influence of preoperative atrial fibrillation on late results of mitral repair: is concomitant ablation justified? Ann Thorac Surg 84 2007 434 442
211. D. Raine, J. Dark, and J.P. Bourke Effect of mitral valve repair/replacement surgery on atrial arrhythmia behavior J Heart Valve Dis 13 2004 615 621
212. J.L. Cox The surgical treatment of atrial fibrillation. IV. Surgical technique J Thorac Cardiovasc Surg 101 1991 584 592
213. J. Kobayashi, Y. Kosakai, and F. Isobe et al. Rationale of the Cox maze procedure for atrial fibrillation during redo mitral valve operations J Thorac Cardiovasc Surg 112 1996 1216 1221
214. A.T. Kawaguchi, Y. Kosakai, and Y. Sasako et al. Risks and benefits of combined maze procedure for atrial fibrillation associated with organic heart disease J Am Coll Cardiol 28 1996 985 990
215. A. Olasinska-Wisniewska, T. Mularek-Kubzdela, and S. Grajek et al. Impact of atrial remodeling on heart rhythm after radiofrequency ablation and mitral valve operations Ann Thorac Surg 93 2012 1449 1455
216. T. Feldman, E. Foster, and D.D. Glower et al. Percutaneous repair or surgery for mitral regurgitation N Engl J Med 364 2011 1395 1406
217. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigattors N Engl J Med 327 1992 685 691
218. C.B. Granger, J.J. McMurray, and S. Yusuf et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial Lancet 362 2003 772 776
219. S.V. Eriksson, P. Eneroth, and J. Kjekshus et al. Neuroendocrine activation in relation to left ventricular function in chronic severe congestive heart failure: a subgroup analysis from the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) Clin Cardiol 17 1994 603 606
220. B. Pitt, F. Zannad, and W.J. Remme et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
221. H. Krum, E.B. Roecker, and P. Mohacsi et al. Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study JAMA 289 2003 712 718
222. M.G. St John Sutton, T. Plappert, and W.T. Abraham et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure Circulation 107 2003 1985 1990
223. R.J. van Bommel, N.A. Marsan, and V. Delgado et al. Cardiac resynchronization therapy as a therapeutic option in patients with moderate-severe functional mitral regurgitation and high operative risk Circulation 124 2011 912 919
224. F. Grigioni, M. Enriquez-Sarano, and K.J. Zehr et al. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment Circulation 103 2001 1759 1764
225. P. Lancellotti, P.L. Gerard, and L.A. Pierard Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation Eur Heart J 26 2005 1528 1532
226. B.H. Trichon, G.M. Felker, and L.K. Shaw et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure Am J Cardiol 91 2003 538 543
227. A. Rossi, F.L. Dini, and P. Faggiano et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy Heart 97 2011 1675 1680
228. K. Fattouch, F. Guccione, and R. Sampognaro et al. POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial J Thorac Cardiovasc Surg 138 2009 278 285
229. T. Mihaljevic, B.K. Lam, and J. Rajeswaran et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation J Am Coll Cardiol 49 2007 2191 2201
230. A.H. Wu, K.D. Aaronson, and S.F. Bolling et al. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction J Am Coll Cardiol 45 2005 381 387
231. K.M. Harris, T.M. Sundt III, and D. Aeppli et al. Can late survival of patients with moderate ischemic mitral regurgitation be impacted by intervention on the valve? Ann Thorac Surg 74 2002 1468 1475
232. U. Benedetto, G. Melina, and A. Roscitano et al. Does combined mitral valve surgery improve survival when compared to revascularization alone in patients with ischemic mitral regurgitation? A meta-analysis on 2479 patients J Cardiovasc Med (Hagerstown) 10 2009 109 114
233. M.A. Deja, P.A. Grayburn, and B. Sun et al. Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial Circulation 125 2012 2639 2648
234. L.H. Cohn, R.J. Rizzo, and D.H. Adams et al. The effect of pathophysiology on the surgical treatment of ischemic mitral regurgitation: operative and late risks of repair versus replacement Eur J Cardiothorac Surg 9 1995 568 574
235. K.M. Chan, P.P. Punjabi, and M. Flather et al. Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial Circulation 126 2012 2502 2510
236. J. Nath, E. Foster, and P.A. Heidenreich Impact of tricuspid regurgitation on long-term survival J Am Coll Cardiol 43 2004 405 409
237. G.D. Dreyfus, P.J. Corbi, and K.M. Chan et al. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg 79 2005 127 132
238. V. Chan, I.G. Burwash, and B.K. Lam et al. Clinical and echocardiographic impact of functional tricuspid regurgitation repair at the time of mitral valve replacement Ann Thorac Surg 88 2009 1209 1215
239. A.M. Calafiore, S. Gallina, and A.L. Iaco et al. Mitral valve surgery for functional mitral regurgitation: should moderate-or-more tricuspid regurgitation be treated? a propensity score analysis Ann Thorac Surg 87 2009 698 703
240. M. Di Mauro, A. Bivona, and A.L. Iaco et al. Mitral valve surgery for functional mitral regurgitation: prognostic role of tricuspid regurgitation Eur J Cardiothorac Surg 35 2009 635 639
241. N.R. Van de Veire, J. Braun, and V. Delgado et al. Tricuspid annuloplasty prevents right ventricular dilatation and progression of tricuspid regurgitation in patients with tricuspid annular dilatation undergoing mitral valve repair J Thorac Cardiovasc Surg 141 2011 1431 1439
242. O. Yilmaz, R.M. Suri, and J.A. Dearani et al. Functional tricuspid regurgitation at the time of mitral valve repair for degenerative leaflet prolapse: the case for a selective approach J Thorac Cardiovasc Surg 142 2011 608 613
243. A.M. Calafiore, A.L. Iaco, and A. Romeo et al. Echocardiographic-based treatment of functional tricuspid regurgitation J Thorac Cardiovasc Surg 142 2011 308 313
244. J.L. Navia, N.A. Brozzi, and A.L. Klein et al. Moderate tricuspid regurgitation with left-sided degenerative heart valve disease: to repair or not to repair? Ann Thorac Surg 93 2012 59 67
245. J.B. Kim, D.G. Yoo, and G.S. Kim et al. Mild-to-moderate functional tricuspid regurgitation in patients undergoing valve replacement for rheumatic mitral disease: the influence of tricuspid valve repair on clinical and echocardiographic outcomes Heart 98 2012 24 30
246. U. Benedetto, G. Melina, and E. Angeloni et al. Prophylactic tricuspid annuloplasty in patients with dilated tricuspid annulus undergoing mitral valve surgery J Thorac Cardiovasc Surg 143 2012 632 638
247. P. Lancellotti, C. Tribouilloy, and A. Hagendorff et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease) Eur J Echocardiogr 11 2010 223 244
248. D.J. Burstow, R.A. Nishimura, and K.R. Bailey et al. Continuous wave Doppler echocardiographic measurement of prosthetic valve gradients. A simultaneous Doppler-catheter correlative study Circulation 80 1989 504 514
249. H. Baumgartner, S. Khan, and M. DeRobertis et al. Effect of prosthetic aortic valve design on the Doppler-catheter gradient correlation: an in vitro study of normal St. Jude, Medtronic-Hall, Starr-Edwards and Hancock valves J Am Coll Cardiol 19 1992 324 332
250. P.M. Vandervoort, N.L. Greenberg, and K.A. Powell et al. Pressure recovery in bileaflet heart valve prostheses. Localized high velocities and gradients in central and side orifices with implications for Doppler-catheter gradient relation in aortic and mitral position Circulation 92 1995 3464 3472
251. J.G. Dumesnil, G.N. Honos, and M. Lemieux et al. Validation and applications of indexed aortic prosthetic valve areas calculated by Doppler echocardiography J Am Coll Cardiol 16 1990 637 643
252. K. Hammermeister, G.K. Sethi, and W.G. Henderson et al. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial J Am Coll Cardiol 36 2000 1152 1158
253. V. Badhwar, J.C. Ofenloch, and J.D. Rovin et al. Noninferiority of closely monitored mechanical valves to bioprostheses overshadowed by early mortality benefit in younger patients Ann Thorac Surg 93 2012 748 753
254. A. Weber, H. Noureddine, and L. Englberger et al. Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age J Thorac Cardiovasc Surg 144 2012 1075 1083
255. M.K. Banbury, D.M. Cosgrove III, and J.D. Thomas et al. Hemodynamic stability during 17 years of the Carpentier-Edwards aortic pericardial bioprosthesis Ann Thorac Surg 73 2002 1460 1465
256. G. Dellgren, T.E. David, and E. Raanani et al. Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis J Thorac Cardiovasc Surg 124 2002 146 154
257. M.A. Borger, J. Ivanov, and S. Armstrong et al. Twenty-year results of the Hancock II bioprosthesis J Heart Valve Dis 15 2006 49 55
258. P.S. Myken, and O. Bech-Hansen A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis J Thorac Cardiovasc Surg 137 2009 76 81
259. H. Oxenham, P. Bloomfield, and D.J. Wheatley et al. Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses Heart 89 2003 715 721
260. P. Stassano, L. Di Tommaso, and M. Monaco et al. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years J Am Coll Cardiol 54 2009 1862 1868
261. S.C. Cannegieter, F.R. Rosendaal, and E. Briet Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses Circulation 89 1994 635 641
262. P.D. Stein, J.S. Alpert, and H.I. Bussey et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves Chest 119 2001 220S 227S
263. A. Schlitt, R.S. von Bardeleben, and A. Ehrlich et al. Clopidogrel and aspirin in the prevention of thromboembolic complications after mechanical aortic valve replacement (CAPTA) Thromb Res 109 2003 131 135
264. M. Torella, D. Torella, and P. Chiodini et al. LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial Am Heart J 160 2010 171 178
265. D. Hering, C. Piper, and R. Bergemann et al. Thromboembolic and bleeding complications following St. Jude Medical valve replacement: results of the German Experience With Low-Intensity Anticoagulation Study Chest 127 2005 53 59
266. J. Acar, B. Iung, and J.P. Boissel et al. AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves Circulation 94 1996 2107 2112
267. D. Horstkotte, R.E. Scharf, and H.P. Schultheiss Intracardiac thrombosis: patient-related and device-related factors J Heart Valve Dis 4 1995 114 120
268. D. Pruefer, M. Dahm, and G. Dohmen Intensity of oral anticoagulation after implantation of St. Jude Medical mitral or multiple valve replacement: lessons learned from GELIA (GELIA 5) Eur Heart J 3 2001 Q43
269. S.S. Meschengieser, C.G. Fondevila, and J. Frontroth et al. Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves J Thorac Cardiovasc Surg 113 1997 910 916
270. A.G. Turpie, M. Gent, and A. Laupacis et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement N Engl J Med 329 1993 524 529
271. M. Heras, J.H. Chesebro, and V. Fuster et al. High risk of thromboemboli early after bioprosthetic cardiac valve replacement J Am Coll Cardiol 25 1995 1111 1119
272. A. Colli, C.A. Mestres, and M. Castella et al. Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial J Heart Valve Dis 16 2007 667 671
273. J.I. Aramendi, C.A. Mestres, and J. Martinez-Leon et al. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial Eur J Cardiothorac Surg 27 2005 854 860
274. L. Nunez, A.M. Gil, and J.L. Larrea et al. Prevention of thromboembolism using aspirin after mitral valve replacement with porcine bioprosthesis Ann Thorac Surg 37 1984 84 87
275. A. Russo, F. Grigioni, and J.F. Avierinos et al. Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications J Am Coll Cardiol 51 2008 1203 1211
276. C. Merie, L. Kober, and O.P. Skov et al. Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding JAMA 308 2012 2118 2125
277. FDA Drug Safety Communication: Pradaxa (dabigatran etexilate mesylate) should not be used in patients with mechanical prosthetic heart valves. FDA. 2012. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm332912.htm. Accessed February 20, 2014.
278. F. Van de Werf, M. Brueckmann, and S.J. Connolly et al. A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN) Am Heart J 163 2012 931 937
279. J.W. Eikelboom, S.J. Connolly, and M. Brueckmann et al. Dabigatran versus warfarin in patients with mechanical heart valves N Engl J Med 369 2013 1206 1214
280. R.T. Weibert, D.T. Le, and S.R. Kayser et al. Correction of excessive anticoagulation with low-dose oral vitamin K1 Ann Intern Med 126 1997 959 962
281. K.H. Yiu, C.W. Siu, and M.H. Jim et al. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves Am J Cardiol 97 2006 409 411
282. J. Barbetseas, S.F. Nagueh, and C. Pitsavos et al. Differentiating thrombus from pannus formation in obstructed mechanical prosthetic valves: an evaluation of clinical, transthoracic and transesophageal echocardiographic parameters J Am Coll Cardiol 32 1998 1410 1417
283. A.T. Tong, R. Roudaut, and M. Ozkan et al. Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE registry J Am Coll Cardiol 43 2004 77 84
284. R. Roudaut, K. Serri, and S. Lafitte Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations Heart 93 2007 137 142
285. E. Deviri, P. Sareli, and T. Wisenbaugh et al. Obstruction of mechanical heart valve prostheses: clinical aspects and surgical management J Am Coll Cardiol 17 1991 646 650
286. R. Roudaut, S. Lafitte, and M.F. Roudaut et al. Fibrinolysis of mechanical prosthetic valve thrombosis: a single-center study of 127 cases J Am Coll Cardiol 41 2003 653 658
287. S. Keuleers, P. Herijgers, and M.C. Herregods et al. Comparison of thrombolysis versus surgery as a first line therapy for prosthetic heart valve thrombosis Am J Cardiol 107 2011 275 279
288. F.M. Caceres-Loriga, H. Perez-Lopez, and K. Morlans-Hernandez et al. Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patients J Thromb Thrombolysis 21 2006 185 190
289. G. Karthikeyan, N.B. Senguttuvan, and J. Joseph et al. Urgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studies Eur Heart J 34 2013 1557 1566
290. R. Roudaut, S. Lafitte, and M.F. Roudaut et al. Management of prosthetic heart valve obstruction: fibrinolysis versus surgery. Early results and long-term follow-up in a single-centre study of 263 cases Arch Cardiovasc Dis 102 2009 269 277
291. D.L. Miller, J.J. Morris, and H.V. Schaff et al. Reoperation for aortic valve periprosthetic leakage: identification of patients at risk and results of operation J Heart Valve Dis 4 1995 160 165
292. C.W. Akins, J.M. Bitondo, and A.D. Hilgenberg et al. Early and late results of the surgical correction of cardiac prosthetic paravalvular leaks J Heart Valve Dis 14 2005 792 799
293. P. Sorajja, A.K. Cabalka, and D.J. Hagler et al. Percutaneous repair of paravalvular prosthetic regurgitation: acute and 30-day outcomes in 115 patients Circ Cardiovasc Interv 4 2011 314 321
294. C.E. Ruiz, V. Jelnin, and I. Kronzon et al. Clinical outcomes in patients undergoing percutaneous closure of periprosthetic paravalvular leaks J Am Coll Cardiol 58 2011 2210 2217
295. P. Sorajja, A.K. Cabalka, and D.J. Hagler et al. Long-term follow-up of percutaneous repair of paravalvular prosthetic regurgitation J Am Coll Cardiol 58 2011 2218 2224
296. J. Lopez, T. Sevilla, and I. Vilacosta et al. Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left-sided infective endocarditis Eur Heart J 2012
297. D.T. Durack, A.S. Lukes, and D.K. Bright New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service Am J Med 96 1994 200 209
298. L.I. Kupferwasser, H. Darius, and A.M. Muller et al. Diagnosis of culture-negative endocarditis: the role of the Duke criteria and the impact of transesophageal echocardiography Am Heart J 142 2001 146 152
299. J.S. Li, D.J. Sexton, and N. Mick et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis Clin Infect Dis 30 2000 633 638
300. A. Perez-Vazquez, M.C. Farinas, and J.D. Garcia-Palomo et al. Evaluation of the Duke criteria in 93 episodes of prosthetic valve endocarditis: could sensitivity be improved? Arch Intern Med 160 2000 1185 1191
301. E. Botelho-Nevers, F. Thuny, and J.P. Casalta et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach Arch Intern Med 169 2009 1290 1298
302. A. Mugge, W.G. Daniel, and G. Frank et al. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach J Am Coll Cardiol 14 1989 631 638
303. A.J. Burger, B. Peart, and H. Jabi et al. The role of two-dimensional echocardiology in the diagnosis of infective endocarditis [corrected] Angiology 42 1991 552 560
304. W.N. Irani, P.A. Grayburn, and I. Afridi A negative transthoracic echocardiogram obviates the need for transesophageal echocardiography in patients with suspected native valve active infective endocarditis Am J Cardiol 78 1996 101 103
305. Y.W. Liu, W.C. Tsai, and C.H. Hsu et al. Judicious use of transthoracic echocardiography in infective endocarditis screening Can J Cardiol 25 2009 703 705
306. W.E. Kemp Jr., B. Citrin, and B.F. Byrd III Echocardiography in infective endocarditis South Med J 92 1999 744 754
307. R. Erbel, S. Rohmann, and M. Drexler et al. Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach. A prospective study Eur Heart J 9 1988 43 53
308. W.G. Daniel, A. Mugge, and R.P. Martin et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography N Engl J Med 324 1991 795 800
309. R.A. Sochowski, and K.L. Chan Implication of negative results on a monoplane transesophageal echocardiographic study in patients with suspected infective endocarditis J Am Coll Cardiol 21 1993 216 221
310. B.K. Shively, F.T. Gurule, and C.A. Roldan et al. Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis J Am Coll Cardiol 18 1991 391 397
311. W.R. Pedersen, M. Walker, and J.D. Olson et al. Value of transesophageal echocardiography as an adjunct to transthoracic echocardiography in evaluation of native and prosthetic valve endocarditis Chest 100 1991 351 356
312. R.E. Ronderos, M. Portis, and W. Stoermann et al. Are all echocardiographic findings equally predictive for diagnosis in prosthetic endocarditis? J Am Soc Echocardiogr 17 2004 664 669
313. M.T. Roe, M.A. Abramson, and J. Li et al. Clinical information determines the impact of transesophageal echocardiography on the diagnosis of infective endocarditis by the duke criteria Am Heart J 139 2000 945 951
314. D.G. Karalis, R.C. Bansal, and A.J. Hauck et al. Transesophageal echocardiographic recognition of subaortic complications in aortic valve endocarditis. Clinical and surgical implications Circulation 86 1992 353 362
315. F. El-Ahdab, D.K. Benjamin Jr., and A. Wang et al. Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia Am J Med 118 2005 225 229
316. E. Mylonakis, and S.B. Calderwood Infective endocarditis in adults N Engl J Med 345 2001 1318 1330
317. S. Rohmann, R. Erbel, and H. Darius et al. Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size J Am Soc Echocardiogr 4 1991 465 474
318. Y. Shapira, D.E. Weisenberg, and M. Vaturi et al. The impact of intraoperative transesophageal echocardiography in infective endocarditis Isr Med Assoc J 9 2007 299 302
319. F. Yao, L. Han, and Z.Y. Xu et al. Surgical treatment of multivalvular endocarditis: twenty-one-year single center experience J Thorac Cardiovasc Surg 137 2009 1475 1480
320. C. Watanakunakorn Staphylococcus aureus endocarditis at a community teaching hospital, 1980 to 1991. An analysis of 106 cases Arch Intern Med 154 1994 2330 2335
321. J. Abraham, C. Mansour, and E. Veledar et al. Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremia Am Heart J 147 2004 536 539
322. A.J. Kaasch, V.G. Fowler Jr., and S. Rieg et al. Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia Clin Infect Dis 53 2011 1 9
323. J. San Martin, C. Sarria, and C. de las Cuevas et al. Relevance of clinical presentation and period of diagnosis in prosthetic valve endocarditis J Heart Valve Dis 19 2010 131 138
324. J.B. Knudsen, K. Fuursted, and E. Petersen et al. Failure of clinical features of low probability endocarditis. The early echo remains essential Scand Cardiovasc J 45 2011 133 138
325. G.M. Feuchtner, P. Stolzmann, and W. Dichtl et al. Multislice computed tomography in infective endocarditis: comparison with transesophageal echocardiography and intraoperative findings J Am Coll Cardiol 53 2009 436 444
326. G. Gahide, S. Bommart, and R. Demaria et al. Preoperative evaluation in aortic endocarditis: findings on cardiac CT AJR Am J Roentgenol 194 2010 574 578
327. S. Lentini, F. Monaco, and F. Tancredi et al. Aortic valve infective endocarditis: could multi-detector CT scan be proposed for routine screening of concomitant coronary artery disease before surgery? Ann Thorac Surg 87 2009 1585 1587
328. E. Fagman, S. Perrotta, and O. Bech-Hanssen et al. ECG-gated computed tomography: a new role for patients with suspected aortic prosthetic valve endocarditis Eur Radiol 22 2012 2407 2414
329. V.G. Fowler Jr., J. Li, and G.R. Corey et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients J Am Coll Cardiol 30 1997 1072 1078
330. R.V. Rasmussen, U. Host, and M. Arpi et al. Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography Eur J Echocardiogr 12 2011 414 420
331. A.L. Sullenberger, L.S. Avedissian, and S.M. Kent Importance of transesophageal echocardiography in the evaluation of Staphylococcus aureus bacteremia J Heart Valve Dis 14 2005 23 28
332. J. Masuda, C. Yutani, and R. Waki et al. Histopathological analysis of the mechanisms of intracranial hemorrhage complicating infective endocarditis Stroke 23 1992 843 850
333. P. Tornos, B. Almirante, and S. Mirabet et al. Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy Arch Intern Med 159 1999 473 475
334. J.L. Carpenter, and C.K. McAllister Anticoagulation in prosthetic valve endocarditis South Med J 76 1983 1372 1375
335. A. Lieberman, W.K. Hass, and R. Pinto et al. Intracranial hemorrhage and infarction in anticoagulated patients with prosthetic heart valves Stroke 9 1978 18 24
336. W.R. Wilson, J.E. Geraci, and G.K. Danielson et al. Anticoagulant therapy and central nervous system complications in patients with prosthetic valve endocarditis Circulation 57 1978 1004 1007
337. K. Ananthasubramaniam, J.N. Beattie, and H.S. Rosman et al. How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage? Chest 119 2001 478 484
338. A.A. Pruitt, R.H. Rubin, and A.W. Karchmer et al. Neurologic complications of bacterial endocarditis Medicine (Baltimore) 57 1978 329 343
339. K.L. Chan, J. Tam, and J.G. Dumesnil et al. Effect of long-term aspirin use on embolic events in infective endocarditis Clin Infect Dis 46 2008 37 41
340. M.C. Fang, A.S. Go, and Y. Chang et al. Death and disability from warfarin-associated intracranial and extracranial hemorrhages Am J Med 120 2007 700 705
341. R.V. Rasmussen, U. Snygg-Martin, and L. Olaison et al. Major cerebral events in Staphylococcus aureus infective endocarditis: is anticoagulant therapy safe? Cardiology 114 2009 284 291
342. F. Jault, I. Gandjbakhch, and A. Rama et al. Active native valve endocarditis: determinants of operative death and late mortality Ann Thorac Surg 63 1997 1737 1741
343. R. Hasbun, H.R. Vikram, and L.A. Barakat et al. Complicated left-sided native valve endocarditis in adults: risk classification for mortality JAMA 289 2003 1933 1940
344. T. Kiefer, L. Park, and C. Tribouilloy et al. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure JAMA 306 2011 2239 2247
345. P. Tornos, E. Sanz, and G. Permanyer-Miralda et al. Late prosthetic valve endocarditis. Immediate and long-term prognosis Chest 101 1992 37 41
346. S.M. Gordon, J.M. Serkey, and D.L. Longworth et al. Early onset prosthetic valve endocarditis: the Cleveland Clinic experience 1992-1997 Ann Thorac Surg 69 2000 1388 1392
347. A. Wang, E. Athan, and P.A. Pappas et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis JAMA 297 2007 1354 1361
348. J.P. Remadi, G. Habib, and G. Nadji et al. Predictors of death and impact of surgery in Staphylococcus aureus infective endocarditis Ann Thorac Surg 83 2007 1295 1302
349. E.E. Hill, P. Herijgers, and P. Claus et al. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study Eur Heart J 28 2007 196 203
350. O. Aksoy, D.J. Sexton, and A. Wang et al. Early surgery in patients with infective endocarditis: a propensity score analysis Clin Infect Dis 44 2007 364 372
351. M.E. Ellis, H. Al-Abdely, and A. Sandridge et al. Fungal endocarditis: evidence in the world literature, 1965 - 1995 Clin Infect Dis 32 2001 50 62
352. M. Wolff, S. Witchitz, and C. Chastang et al. Prosthetic valve endocarditis in the ICU. Prognostic factors of overall survival in a series of 122 cases and consequences for treatment decision Chest 108 1995 688 694
353. C. Chirouze, C.H. Cabell, and V.G. Fowler Jr. et al. Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database Clin Infect Dis 38 2004 1323 1327
354. G.R. Melgar, R.M. Nasser, and S.M. Gordon et al. Fungal prosthetic valve endocarditis in 16 patients. An 11-year experience in a tertiary care hospital Medicine (Baltimore) 76 1997 94 103
355. K. Wang, F. Gobel, and D.F. Gleason et al. Complete heart block complicating bacterial endocarditis Circulation 46 1972 939 947
356. S. Middlemost, T. Wisenbaugh, and C. Meyerowitz et al. A case for early surgery in native left-sided endocarditis complicated by heart failure: results in 203 patients J Am Coll Cardiol 18 1991 663 667
357. K.L. Chan Early clinical course and long-term outcome of patients with infective endocarditis complicated by perivalvular abscess CMAJ 167 2002 19 24
358. F. Jault, I. Gandjbakhch, and J.C. Chastre et al. Prosthetic valve endocarditis with ring abscesses. Surgical management and long-term results J Thorac Cardiovasc Surg 105 1993 1106 1113
359. I. Anguera, J.M. Miro, and I. Vilacosta et al. Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality Eur Heart J 26 2005 288 297
360. L.M. Klieverik, M.H. Yacoub, and S. Edwards et al. Surgical treatment of active native aortic valve endocarditis with allografts and mechanical prostheses Ann Thorac Surg 88 2009 1814 1821
361. E.E. Hill, P. Herijgers, and P. Claus et al. Abscess in infective endocarditis: the value of transesophageal echocardiography and outcome: a 5-year study Am Heart J 154 2007 923 928
362. M.B. Manne, N.K. Shrestha, and B.W. Lytle et al. Outcomes after surgical treatment of native and prosthetic valve infective endocarditis Ann Thorac Surg 93 2012 489 493
363. M.R. Sohail, D.Z. Uslan, and A.H. Khan et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection Mayo Clin Proc 83 2008 46 53
364. E. Athan, V.H. Chu, and P. Tattevin et al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices JAMA 307 2012 1727 1735
365. H. Rundstrom, C. Kennergren, and R. Andersson et al. Pacemaker endocarditis during 18 years in Goteborg Scand J Infect Dis 36 2004 674 679
366. H.H. Ho, C.W. Siu, and K.H. Yiu et al. Prosthetic valve endocarditis in a multicenter registry of Chinese patients Asian Cardiovasc Thorac Ann 18 2010 430 434
367. F. Thuny, G. Di Salvo, and O. Belliard et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study Circulation 112 2005 69 75
368. D.H. Kang, Y.J. Kim, and S.H. Kim et al. Early surgery versus conventional treatment for infective endocarditis N Engl J Med 366 2012 2466 2473
369. C. Schaefer Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity Birth Defects Res A Clin Mol Teratol 67 2003 591 594
370. W.O. Cooper, S. Hernandez-Diaz, and P.G. Arbogast et al. Major congenital malformations after first-trimester exposure to ACE inhibitors N Engl J Med 354 2006 2443 2451
371. A. Shotan, J. Widerhorn, and A. Hurst et al. Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use Am J Med 96 1994 451 456
372. A.M. Abouzied, M. Al Abbady, and M.F. Al Gendy et al. Percutaneous balloon mitral commissurotomy during pregnancy Angiology 52 2001 205 209
373. F.M. Ben, H. Gamra, and F. Betbout et al. Percutaneous balloon mitral commissurotomy during pregnancy Heart 77 1997 564 567
374. J.A. de Souza, E.E. Martinez Jr., and J.A. Ambrose et al. Percutaneous balloon mitral valvuloplasty in comparison with open mitral valve commissurotomy for mitral stenosis during pregnancy J Am Coll Cardiol 37 2001 900 903
375. J.C. Glantz, R.M. Pomerantz, and M.J. Cunningham et al. Percutaneous balloon valvuloplasty for severe mitral stenosis during pregnancy: a review of therapeutic options Obstet Gynecol Surv 48 1993 503 508
376. B. Iung, B. Cormier, and J. Elias et al. Usefulness of percutaneous balloon commissurotomy for mitral stenosis during pregnancy Am J Cardiol 73 1994 398 400
377. N. Tzemos, C.K. Silversides, and J.M. Colman et al. Late cardiac outcomes after pregnancy in women with congenital aortic stenosis Am Heart J 157 2009 474 480
378. A.P. Banning, J.F. Pearson, and R.J. Hall Role of balloon dilatation of the aortic valve in pregnant patients with severe aortic stenosis Br Heart J 70 1993 544 545
379. T.R. Easterling, H.S. Chadwick, and C.M. Otto et al. Aortic stenosis in pregnancy Obstet Gynecol 72 1988 113 118
380. T.T. Lao, A.G. Adelman, and M. Sermer et al. Balloon valvuloplasty for congenital aortic stenosis in pregnancy Br J Obstet Gynaecol 100 1993 1141 1142
381. R.A. McIvor Percutaneous balloon aortic valvuloplasty during pregnancy Int J Cardiol 32 1991 1 3
382. S.G. Myerson, A.R. Mitchell, and O.J. Ormerod et al. What is the role of balloon dilatation for severe aortic stenosis during pregnancy? J Heart Valve Dis 14 2005 147 150
383. R.T. Tumelero, N.T. Duda, and A.P. Tognon et al. Percutaneous balloon aortic valvuloplasty in a pregnant adolescent Arq Bras Cardiol 82 2004 98-7
384. W.S. Chan, S. Anand, and J.S. Ginsberg Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature Arch Intern Med 160 2000 191 196
385. S.S. Meschengieser, C.G. Fondevila, and M.T. Santarelli et al. Anticoagulation in pregnant women with mechanical heart valve prostheses Heart 82 1999 23 26
386. U. Abildgaard, P.M. Sandset, and J. Hammerstrom et al. Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin Thromb Res 124 2009 262 267
387. C. McLintock, L.M. McCowan, and R.A. North Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin BJOG 116 2009 1585 1592
388. B. Oran, A. Lee-Parritz, and J. Ansell Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy Thromb Haemost 92 2004 747 751
389. J. Quinn, K. Von Klemperer, and R. Brooks et al. Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experience Haematologica 94 2009 1608 1612
390. M. Sillesen, V. Hjortdal, and N. Vejlstrup et al. Pregnancy with prosthetic heart valves - 30 years' nationwide experience in Denmark Eur J Cardiothorac Surg 40 2011 448 454
391. L.S. De Santo, G. Romano, and A. Della Corte et al. Mechanical aortic valve replacement in young women planning on pregnancy: maternal and fetal outcomes under low oral anticoagulation, a pilot observational study on a comprehensive pre-operative counseling protocol J Am Coll Cardiol 59 2012 1110 1115
392. E. Salazar, R. Izaguirre, and J. Verdejo et al. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses J Am Coll Cardiol 27 1996 1698 1703
393. N. Vitale, M. De Feo, and M. Cotrufo Anticoagulation for prosthetic heart valves during pregnancy: the importance of warfarin daily dose Eur J Cardiothorac Surg 22 2002 656
394. J.A. Rowan, L.M. McCowan, and P.J. Raudkivi et al. Enoxaparin treatment in women with mechanical heart valves during pregnancy Am J Obstet Gynecol 185 2001 633 637
395. A.H. James, L.R. Brancazio, and T.R. Gehrig et al. Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves J Matern Fetal Neonatal Med 19 2006 543 549
396. Y. Yinon, S.C. Siu, and C. Warshafsky et al. Use of low molecular weight heparin in pregnant women with mechanical heart valves Am J Cardiol 104 2009 1259 1263
397. J.S. Ginsberg, W.S. Chan, and S.M. Bates et al. Anticoagulation of pregnant women with mechanical heart valves Arch Intern Med 163 2003 694 698
398. D.B. Mark, D.S. Berman, and M.J. Budoff et al. ACCF/ACR/AHA/NASCI/SAIP/ SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents J Am Coll Cardiol 55 2010 2663 2699
399. M. Gilard, J.C. Cornily, and P.Y. Pennec et al. Accuracy of multislice computed tomography in the preoperative assessment of coronary disease in patients with aortic valve stenosis J Am Coll Cardiol 47 2006 2020 2024
400. N.E. Manghat, G.J. Morgan-Hughes, and A.J. Broadley et al. 16-detector row computed tomographic coronary angiography in patients undergoing evaluation for aortic valve replacement: comparison with catheter angiography Clin Radiol 61 2006 749 757
401. W.B. Meijboom, N.R. Mollet, and C.A. Van Mieghem et al. Pre-operative computed tomography coronary angiography to detect significant coronary artery disease in patients referred for cardiac valve surgery J Am Coll Cardiol 48 2006 1658 1665
402. P. Reant, S. Brunot, and S. Lafitte et al. Predictive value of noninvasive coronary angiography with multidetector computed tomography to detect significant coronary stenosis before valve surgery Am J Cardiol 97 2006 1506 1510
403. H. Scheffel, S. Leschka, and A. Plass et al. Accuracy of 64-slice computed tomography for the preoperative detection of coronary artery disease in patients with chronic aortic regurgitation Am J Cardiol 100 2007 701 706
404. A. Galas, T. Hryniewiecki, and C. Kepka et al. May dual-source computed tomography angiography replace invasive coronary angiography in the evaluation of patients referred for valvular disease surgery? Kardiol Pol 70 2012 877 882
405. G. Doukas, N.J. Samani, and C. Alexiou et al. Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial JAMA 294 2005 2323 2329
406. C. Blomstrom-Lundqvist, B. Johansson, and E. Berglin et al. A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation study (SWEDMAF) Eur Heart J 28 2007 2902 2908
407. X. Liu, H.W. Tan, and X.H. Wang et al. Efficacy of catheter ablation and surgical CryoMaze procedure in patients with long-lasting persistent atrial fibrillation and rheumatic heart disease: a randomized trial Eur Heart J 31 2010 2633 2641
408. A.M. Calleja, S. Dommaraju, and R. Gaddam et al. Cardiac risk in patients aged >75 years with asymptomatic, severe aortic stenosis undergoing noncardiac surgery Am J Cardiol 105 2010 1159 1163
409. M. Zahid, A.F. Sonel, and S. Saba et al. Perioperative risk of noncardiac surgery associated with aortic stenosis Am J Cardiol 96 2005 436 438
410. L.C. Torsher, C. Shub, and S.R. Rettke et al. Risk of patients with severe aortic stenosis undergoing noncardiac surgery Am J Cardiol 81 1998 448 452
411. S. Agarwal, A. Rajamanickam, and N.S. Bajaj et al. Impact of aortic stenosis on postoperative outcomes after noncardiac surgeries Circ Cardiovasc Qual Outcomes 6 2013 193 200